Invacare Platinum 5NXG Oxygen Concentrator— 510(k) K203210

Substantially Equivalent

Invacare Corporation

FDA 510(k) clearance K203210 for Invacare Platinum 5NXG Oxygen Concentrator, Substantially Equivalent on 2021-04-12. Applicant: Invacare Corporation.

Clearance details

Applicant: Invacare Corporation
Product code: Code CAW
Advisory panel: Anesthesiology
Date received: 2020-10-30
Decision date: 2021-04-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Elyria, OH, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code CAW

product code CAW

Death: 204
Injury: 573
Malfunction: 1,400
Other: 6
Total: 2,183

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.